Sampson, Laura http://orcid.org/0000-0002-1715-2081
Martins, Silvia S.
Yu, Shui
Chiavegatto Filho, Alexandre Dias Porto
Andrade, Laura Helena
Viana, Maria Carmen
Medina-Mora, Maria Elena
Benjet, Corina
Torres, Yolanda
Piazza, Marina
Aguilar-Gaxiola, Sergio
Cia, Alfredo H.
Stagnaro, Juan Carlos
Zaslavsky, Alan M.
Kessler, Ronald C.
Galea, Sandro
Funding for this research was provided by:
National Institute of Mental Health (R01 MH070884)
John D. and Catherine T. MacArthur Foundation (R13-MH066849)
Pfizer Foundation (R01- MH069864)
U.S. Public Health Service (R01 DA016558)
Fogarty International Center (FIRCA R03-TW006481)
Pan American Health Organization
Eli Lilly and Company
Ortho-McNeil Pharmaceutical
GlaxoSmithKline
Bristol-Myers Squibb
Ministerio de Salud de la Nación
State of São Paulo Research Foundation (03/00204-, 16/50307-3)
Center for Excellence on Research in Mental Health
Secretary of Health of Medellín
National Institute of Psychiatry Ramon de la Fuente Muñiz (INPRFM/DIES 4280)
National Council on Science and Technology (CONACyT- G30544- H)
National Institute of Health of the Ministry of Health of Peru
Brazilian Council for Scientific and Technological Development (307784/2016-9)
Article History
Received: 26 December 2017
Accepted: 20 August 2018
First Online: 1 September 2018
Compliance with ethical standards
:
: In the past 3 years, Dr. Kessler received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Sage Pharmaceuticals, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services Inc. Lake Nona Life Project. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. Other authors have no financial or personal conflicts of interest to disclose.